Nicholas Investment Partners, LP - NEUROCRINE BIOSCIENCES INC ownership

NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 56 filers reported holding NEUROCRINE BIOSCIENCES INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Nicholas Investment Partners, LP ownership history of NEUROCRINE BIOSCIENCES INC
ValueSharesWeighting
Q2 2020$989,000
-30.8%
595,000
-46.6%
0.20%
-27.7%
Q1 2020$1,429,000
-35.6%
1,115,000
-23.1%
0.28%
+21.4%
Q4 2019$2,220,000
-53.7%
1,450,000
-58.6%
0.23%
-43.2%
Q3 2019$4,792,000
+52.2%
3,500,000
+45.8%
0.40%
+39.4%
Q2 2019$3,149,000
+102.6%
2,400,000
+108.7%
0.29%
+107.9%
Q1 2019$1,554,000
-16.0%
1,150,000
-25.8%
0.14%
-30.2%
Q4 2018$1,850,000
+97.2%
1,550,000
+181.8%
0.20%
+165.3%
Q3 2018$938,000
-44.7%
550,000
-53.2%
0.08%
-37.0%
Q2 2018$1,696,0001,175,0000.12%
Other shareholders
NEUROCRINE BIOSCIENCES INC shareholders Q4 2019
NameSharesValueWeighting ↓
CSS LLC/IL 15,659,000$23,207,6871.52%
SONA ASSET MANAGEMENT (US) LLC 17,500,000$26,317,9521.09%
TENOR CAPITAL MANAGEMENT Co., L.P. 26,765,000$40,113,0990.86%
Warberg Asset Management LLC 1,271,000$1,885,8460.38%
SSI INVESTMENT MANAGEMENT LLC 2,296,000$3,406,1160.28%
Paloma Partners Management Co 3,125,000$4,694,5900.16%
FRANKLIN RESOURCES INC 54,750,000$81,769,1250.04%
Rock Springs Capital Management LP 1,000,000$1,497,9500.04%
LORD, ABBETT & CO. LLC 4,666,000$6,9220.03%
D. E. Shaw & Co., Inc. 14,351,000$21,373,1970.02%
View complete list of NEUROCRINE BIOSCIENCES INC shareholders